Epidemiology of Escherichia coli bloodstream infection antimicrobial resistance trends across South West England during the first 2 years of the coronavirus disease 2019 pandemic response

This publication has 12 references indexed in Scilit:

• Changes in social contacts in England during the COVID-19 pandemic between March 2020 and March 2021 as measured by the CoMix survey: A repeated cross-sectional study
  PLOS Medicine, 2022
• Impact of the COVID-19 Pandemic on the Prescribing Patterns of First-Line Antibiotics in English Primary Care: A Longitudinal Analysis of National Prescribing Dataset
  Antibiotics, 2021
• Interrupted time series analysis using autoregressive integrated moving average (ARIMA) models: a guide for evaluating large-scale health interventions
  BMC Medical Research Methodology, 2021
• Hand hygiene improvement or antibiotic restriction to control the household transmission of extended-spectrum β-lactamase-producing Escherichia coli: a mathematical modelling study
  Antimicrobial Resistance & Infection Control, 2020
• Changes in resistance among coliform bacteraemia associated with a primary care antimicrobial stewardship intervention: A population-based interrupted time series study
  PLOS Medicine, 2019
• A Large, Refractory Nosocomial Outbreak of Klebsiella pneumoniae Carbapenemase-Producing Escherichia coli Demonstrates Carbapenemase Gene Outbreaks Involving Sink Sites Require Novel Approaches to Infection Control
  Antimicrobial Agents and Chemotherapy, 2018
• Epidemiology of Escherichia coli bacteraemia in England: results of an enhanced sentinel surveillance programme
  Journal of Hospital Infection, 2017
• Escherichia coli: an old friend with new tidings
  FEMS Microbiology Reviews, 2016
• Colonisation with Escherichia coli resistant to “critically important” antibiotics: a high risk for international travellers
  European Journal of Clinical Microbiology & Infectious Diseases, 2010
• Segmented regression analysis of interrupted time series studies in medication use research
  Journal of Clinical Pharmacy and Therapeutics, 2002